Theralase grants 7 million stock options at C$ 0.265 per share

PUBT · 1d ago
Theralase grants 7 million stock options at C$ 0.265 per share
  • Theralase granted 7,000,000 stock options under its stock option plan.
  • Options carry an exercise price of C$ 0.27 per common share.
  • Awards vest over three years; options expire five years from the grant date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theralase Technologies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608071725NEWSFILECNPR____20260807_308758_1) on August 07, 2026, and is solely responsible for the information contained therein.